Thursday, February 28, 2019

Recombinant Therapeutic Antibodies & Proteins Market Future Opportunities 2023

Human proteins obtained through genetic engineering rather than from tissue samples have played a vital role in therapeutic medicines market. Advances in pharmacological understanding and pharmaceutical production have allowed continuous development of human proteins as a vital therapeutic option in variety of human diseases. From a clinical perspective, therapeutic proteins provide essential therapies in various life threatening disease such as diabetes, viral hepatitis, end-stage renal disease, clotting disorders and other metabolic disorders. Proteins as a part of the natural metabolism are synthesized by the living organism. Proteins play a significant role in carrying out vital body functions such as cell signaling, immune responses, cell adhesion, and the cell cycle. Industries such as biopharmaceutical industry, enzyme industry, and agriculture industry over a decade have been significantly benefited from native and recombinant proteins. In general therapeutic proteins include antibody-based drugs, bone morphogenetic proteins, FC fusion proteins, hormones, interleukins, and anticoagulants. Major application areas for these recombinant proteins include multiple sclerosis, dwarfism, anemia, rheumatoid arthritis, Crohn’s disease, diabetes and others.
Increasing investment on research activities and introduction of new protein therapeutics has significantly contributed in growth and development of recombinant therapeutic antibodies and proteins market. Moreover rising number of clinical trials in pharmaceutical industry have also contributed in growth and development of market in past few years. Owing to increased focus on developing innovative monoclonal antibodies (mAb), this segment is expected to dominate during the forecast period. Interestingly, although the recombinant therapeutic and proteins market is significantly smaller than overall pharmaceutical market yet the growth rate of the market is significantly higher than the overall pharmaceutical market. Restraint to the growth of the market includes lack of variety in formulations as most the recombinant antibodies and proteins can only be administered via injections. There are several problems associated with the administration of protein drug via injection such as it increases the overall cost of the treatment, need of trained caregiver during the course of treatment barring a few such as insulin and others. Additionally patent expiration of branded drugs and budget constraints are another major factor limiting the growth and exploration of application areas.
Geographically the market is largely dominated by the developed economic regions such as North America and Europe owing to rapid growth of the biotechnology derived techniques in these two regions. Additionally significant research support in terms of infrastructure and funding has also driven recombinant therapeutic antibodies and proteins market in past one decade. Emerging markets such as Asia Pacific and Rest of the World market are expected to be the fastest growing market pertaining to developing economic scenario and increasing demand for therapeutics market. Owing to such reforms and growth in developing economic countries have successfully contributed in attracting prominent players to these regions as a strategy to increase customer base and business expansion. Major branded monoclonal antibodies in the market include Rituxan (rituxumab), Synagis (Palivizumab), Campath (Alemtuzumab), Erbitux (Cetuximab). Whereas branded therapeutic proteins in the market comprises Levemir (Datemir insulin), Neulasta (PEG-Filgrastim), Enbrel (Etanercept), Ontak (rIL2-diptheria toxin) and others. Recombinant proteins currently in clinical trial phase include AERAS-404, Interferon alpha2a Fusion Protein, Anakinra, Aldesleukin and others.
Some of the prominent players operating in the global recombinant therapeutic antibodies and protein market include Bristol-Myers Squibb, Celldex Therapeutics, Inc., Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Novartis International AG, Schering AG, Johnson & Johnson and others.
Posted by at No comments:
Labels:

Thymus Cancer Market Size, Share & Trend | Industry Analysis Report, 2025

Thymus is an irregular shape gland which is located under the breastbone (sternum) in upper chest. The organ is divided into two halves known as lobes and is made up of many small bumps called as lobules. Thymus plays an important role in maintaining the body’s immune system. During fetal development and childhood thymus gland is involved in the production and maturation of T lymphocytes (T cells). T cells are developed in the thymus and travel to lymph nodes throughout the body. These T cells are responsible for fighting against viruses, bacteria, fungi and various other infection causing agent. Thymus gland is fully developed at the age of puberty but gradually the gland shrinks and becomes inactive. However, the gland continues to produce T cells until old age.
Thymus cancers (Thymomas and thymic cancers) are rare tumors and originate from thymic epithelial cells. It is estimated, in the U.S that approximately 400 cases per year are diagnosed for thymus cancers. People suffering from thymomas show symptoms of shortness of breath, cough, chest pain, weight loss and others. The cancer is benign and people aged between 40 years and 60 years are usually diagnosed with thymomas. As thymus gland is involved in production of T cells, people suffering from thymus cancers tend to show immune system related illness. For, instance 30% to 50% of people suffering from thymomas show myasthenia gravis (MG), disease condition in which immune system forms antibodies for blocking chemical signals required for muscle movement.
Currently, thymus cancers are diagnosed with the help of various tests including chest X-ray, CT scan, PET scan, Needle biopsy, MRI scan, thoracoscopy and mediastinoscopy. Additionally, surgery and chemotherapy are the main treatment options available for the removal of thymus cancers. Further, clinical trials are being conducted for the treatment of thymus cancer. Some of major players involved in conducting clinical trial therapeutics are Novartis AG, Enzon Pharmaceuticals, Inc. and Nerviano Medical Sciences S.r.l.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Lower Limb Ulcer Treatment Market Future Opportunities 2025

Lower limb ulcer is the most prevalent ulcer type among all chronic wounds, which impose significantly large economic burden in every country. Treatment of lower limb ulcer is regulated with guidelines within each country, including guidelines from assessment of leg to the final stages of wound management. The important aspects of treatment of lower limb ulcers include periwound protection, frequency of dressing changes, exudate management, and debridement. Rising incidence rate of lower limb ulcer has intensified the need for dressings that offer faster and efficient wound management and healing. The lower limb ulcer treatment market is witnessing unprecedented dynamics in terms of changing government guidelines, establishment of reimbursement, and increasing awareness about treatment and diagnosis to reduce the economic burden.
The global lower limb ulcer treatment market is characterized by the trend of continuous innovations in the treatment approach of lower limb ulcers. The different innovations in the lower limb ulcer therapies include, but are not limited to, estrogen treatment, combination compression therapy, cold skin therapy, etc. The significant unmet clinical needs in the global market present significant opportunities for emerging players. Increasing treatment cost for chronic wounds, rising awareness about availability of advanced products in the market, growing adoption of active therapies and silver absorbent dressings for wound treatment, significant emphasis on infection management of lower limb ulcers are the factors driving the market. However, limited profit margins in some regions due to regulatory policies and market entry barriers are likely to act as restraints of the market.
The global lower limb ulcer treatment market can be categorized based on ulcer type, product type, end-user, and region. In terms of ulcer type, the market can be divided into arterial leg ulcer, venous leg ulcer, and others. Venous leg ulcer is among the most prevalent type of lower limb ulcer. However, a significant number of people have arterial insufficiency. Arterial leg ulcers occur due to inadequate blood supply to the skin, which may be caused by atherosclerosis Based on product type, the market can be segmented into moist dressings, antimicrobial dressings, and active therapies. The moist dressings segment can be sub-divided into film dressings, hydrofiber dressings, hydrogel dressings, hydrocolloid dressings, alginate dressings, foam dressings, and collagen dressings. The antimicrobial dressings segment can be bifurcated into silver dressings and non-silver dressings. The active therapies segment can be classified into artificial skin and skin substitutes, and growth factors. In terms of end-user, the market can be classified into hospitals, clinics, long-term care centers, skilled nursing facilities, and ambulatory care centers.
In terms of region, the global lower limb ulcer treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is projected to register significant growth due to large patient pool for long term chronic pathologies, increasing investment in outpatient settings, and rising treatment compliance. North America, followed by Europe, is likely to continue to dominate the global market during the forecast period. The market in these two regions is characterized by increasing innovations in advanced treatment, favorable reimbursement policies, and rising population aged above 65 years as a percentage of the overall population. Superior technological innovations in wound management for lower limb ulcers is anticipated to boost the growth of the global market in the near future.
Key players operating in the global lower limb ulcer treatment market include 3M Company, Coloplast A/S, Acelity L.P., Inc., ConvaTec, Inc., Smith & Nephew plc, B. Braun Melsungen AG, BSN medical GMBH, Molnlycke Health Care AB, Medline Industries, Inc., Hollister Incorporated, Medtronic, Ferris Mfg. Corp., Beiersdorf AG, and Cardinal Health among others.
Posted by at No comments:
Labels:

Gel Documentation Systems Market Key Manufacturers, Development Trends And Competitive Analysis 2025

Gel document system is a gel imaging instrument used to record and measure stained agarose gel and acrylamide gels on digital platforms. This equipment has extensive application in molecular biology laboratories and clinical research centers for the imaging and documentation of nucleic acid and proteins stained in agarose gels. Apart from imaging and documentation of nucleic acids and proteins, gel documentation systems provide accurate sample quantification. The gels used in gel documentation systems are usually stained with ethidium bromide or flurophores such as SYBR green to visualize the sample under UV light. Gel documentation systems comprise ethidium bromide (UV) light transilluminator, a hood to protect external light sources and the user from UV exposure, and a charged-couple device (CCD) or complementary metal-oxide semiconductor (CMOS) camera to capture images. It also comprises fluorescence, densometric, chemiluminescence, and visible light detectors for quantification of nucleic acid and protein bands. It has considerable application in gel and blot imaging, colony counting, immunoassay, multiplex protein detection, 1-D and 2-D electrophoresis, monoclonal and polyclonal antibodies affinities and post transitional modification characterization.
Gel documentation systems have transformed rapidly in the last decade in terms of functionality, reliability, ease of use, and affordability. These technological developments in gel documentation systems offer researchers many advantages such as faster and high quality images, faster exposure time, and greater efficiency. Technological developments in gel documentation systems with improved efficiency and reduced time is projected to be a key driving factor during the forecast period. Polymerase chain reaction (PCR) technique is commonly used in medical and biological research institutes to detect the presence or absence of gene to help identify pathogens during infection, and to generate forensic DNA profiles. Growing awareness and usage of PCR techniques for early diagnosis of infectious diseases and designing optimum treatment methods are projected to contribute to growth of the global gel documentation systems market. Moreover, increasing number of clinical laboratories, academic, medical, and research institutes, diagnostics centers, and growing pharmaceutical and biotechnological industries would drive the demand for gel documentation systems worldwide. On the flip side, the high cost of modern gel documentation systems with modern technologies, and limited resources of skilled professionals in under developed and developing countries in the field of clinical and laboratory research would hamper the growth of the global gel documentation systems market.
The global gel documentation systems market has been broadly classified into four segments based on type, application, end user, and geography. Based on type, gel documentation systems are segmented into film gel documentation system and digital gel documentation system. Digital gel documentation system is projected to account for key market share and is likely to grow at exponential growth rates during the forecast period. By application, the global gel documentation systems market is segmented as fluorescence detector, chemiluminescence detector, and others. End users of gel documentation systems include hospitals, diagnostic centers, academic, medical and research institutes, and pharmaceutical and biotechnological companies. Diagnostics centers are projected to be key shareholders and expand at the highest CAGR during the forecast period.
The global gel documentation systems market in terms of geography is segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global gel documentation systems market by the end of forecast period owing to high clinical R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies, and early adoption of modern technologies. Europe is projected to be the second leading region in the global gel documentation systems market. The market in the Asia Pacific region is projected to expand at the highest growth rate primarily due to growing number of hospitals and diagnostics centers, and increasing investments by global pharmaceutical and biotechnology companies in this region. Also, growing burden of infectious diseases in South East Asia is generating high demand for early diagnosis and detection of infectious diseases. This is considered to be a key driving factor for the growth of the Asia Pacific gel documentation market during the forecast period.
The key global players operating in the global gel documentation systems market includes Synoptics Ltd., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., GE Healthcare, Analytik Jena AG, Azure Biosystems, Inc, Labnet International, Inc., Biobase Group, and Maestrogen. Out of these, Synoptics Ltd., Bio-Rad Laboratories, and Thermo Fisher Scientific Inc. account for key share of the global gel documentation systems market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Minimally Invasive Anti-Ageing Treatment Market: Analysis and Research Report by Experts 2027

Minimally invasive anti-ageing treatments that do not require any penetration into the skin. Non-invasive procedures cover a number of diagnostic and therapeutic procedures, such as chiropractic manipulation, physical therapy, and heat therapy. Minimally invasive treatments refer to a range of procedures that involve tiny injections and exclude any surgical invasion into the human body. The most common treatments are injections with botulinum toxin (Botox), dermal fillers, lipofilling, and microdermabrasion (non-chemical). Lasers, chemical peels and facials, and cosmeceuticals (a combination of cosmetics and pharmaceuticals) are also considered as minimally invasive treatments. Botax remains mainstay for minimally invasive or non-invasive anti-ageing treatment or procedure in various geographies.
Minimally Invasive Anti-Ageing Treatment Market: Drivers and Restraints
Global minimally invasive anti-ageing treatment market is expected to grow at significant rate owing to lesser cost of treatment than high tech devices, effective and affordable alternative to plastic surgery procedures. The factors currently contributing to the revenue growth of the minimally invasive anti-ageing treatment market is requirement of little to no downtime for these procedures and minimally invasive treatments require very small incisions or injections sites, resulting in less pain and very few post-procedure complications. Furthermore, emerging middle class and rapidly aging world population are expected to drive the market for minimally invasive anti-ageing treatment over the forecast period.
Global minimally invasive anti-ageing treatment market may hinder owing to non-permanent nature of these treatments which requires re-treatment in given specific period of time which is expected to affect the market negatively over the forecast period. The minimally invasive anti-ageing treatment market may restrained by side effects associated with treatment such as mild swelling and bleeding, and occasional skin imperfections which are expected to hinder market revenue growth over the forecast period
Minimally Invasive Anti-Ageing Treatment Market: Segmentation
Global minimally invasive anti-ageing treatment market has been segmented on the basis of treatment type, route of administration, distribution channel, and region
Minimally Invasive Anti-Ageing Treatment Market: Overview
Global minimally invasive anti-ageing treatment market is witnessing significant changes due to rising uptake of combination treatments across the globe. Rising number of dermatology clinics in Asia Pacific and Latin America region and increasing access to products and services owing to OTC formulations in the market expected create significant market changes over the forecast period.
Minimally Invasive Anti-Ageing Treatment Market: Region-wise Outlook
Geographically, minimally invasive anti-ageing treatment market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Western Europe will remain key markets for Minimally Invasive Anti-Ageing Treatment products due to increased awareness among key stakeholders, rising preference for aesthetics, and increasing affordability and innovation all these factors together helps to maintain larger market revenue share in the global minimally invasive anti-ageing treatment market by these regions. Asia Pacific is anticipated to present better growth opportunity owing to availability of large addressable population and favourable demographic dividend in the region.
Minimally Invasive Anti-Ageing Treatment Market: Key Players
Some of the players in the global Minimally Invasive Anti-Ageing Treatment Market are Galderma S.A., Allergan Plc., Johnson & Johnson Services, Inc., Valeant Pharmaceuticals International, Inc., Alma Lasers Ltd., Lumenis Ltd., Merz Pharma GmbH & Co. KGaA,, Cutera, Inc., Syneron Medical Ltd. to name a few.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Custom Primer Generation Service Market: Growth Analysis, Trends and Scope till 2024

Primer is a small strand of DNA or RNA used in DNA synthesis as a preliminary point. The size of primers is generally not more than 30 nucleotides and these exactly match the end and beginning of the DNA section to be amplified. The primers adhere at the beginning and endpoint of DNA template, where DNA polymerase muddles and initiates the production of the new DNA strand.
The temperature, at which half of DNA molecule types form a stable double helix and remaining half are detached to solitary strand molecule, is called melting temperature of primer, generally between about 55 °C and 65 °C. Melting temperature is required to increase the length of primer and the temperature is decreased to stop or limit the length. Primers that are too small would adhere at numerous places on a lengthy DNA template, and results in non-specific copies. The primer sequence should be unique in nature to avoid the possibility of mishybridization to a similar sequence nearby. The ideal primer should not adhere to other primer and to themselves strongly, as internal loop could hamper the annealing with the template DNA. Custom primers are widely used for sequencing libraries.
The custom primer generation service market has been segmented based on type of service, application, and end-user. In terms of type of service, the market has been categorized into primer design service and primer synthesis or sequencing. The one-stop custom qPCR primer design service is designed to save money, time, and efforts by avoiding failure or complication in qPCR experiments. For a successful qPCR, a pair of good designed primers is one of the main requirements. The primer sequencing services segment comprises two types: tube sequencing and plate sequencing. Plate sequencing are of two types: short sequencing plates and ready to load plates.
In terms of application, the custom primer generation service market has been segmented into research, therapeutics, and diagnostics. The research segment has been categorized into PCR, qPCR, DNA sequencing, gene synthesis, and other research applications. The therapeutics segment has been sub-segmented into DNA/antisense oligos, RNA, nucleic acid aptamers, and immunotherapy. Increasing applications of custom primers in library preparations, nucleic acid array-based technologies, genomics, next-generation sequencing (NGS), nucleic acid-base detections, diagnostics, cell cultures, human identity testing, therapeutics, cloning, and synthetic biology and genetic engineering are likely to propel the custom prime generation service market.
In terms of end-user, the custom primer generation service market has been segmented into academic research institutes, diagnostic laboratories, pharmaceutical and biotechnology companies, and others. The diagnostics segment is expected to expand at a high CAGR owing to rising adoption of novel technologies and services in the segment. The academic research institutes segment is expected to witness strong growth during the forecast period due to rising research activities globally.
In terms of region, the custom primer generation service market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the major share of the global custom primer generation service market owing to increasing awareness about the applications of synthetic genes in the region. Additionally, increasing funding from public and private sector organizations for research is anticipated to boost the custom primer generation service market. Asia Pacific is the most progressive region for the custom primer generation service market due to product availability and research and development funding in the region.
Major factors boosting the growth of this market include rising demand for synthesized primer generation, increasing R&D expenses by pharmaceutical companies, and growing government participation in development of genomics.
Major players in the custom primer generation service market are Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Eurofins Genomics, Bioautomation Corporation, General Electric Company, Integrated DNA Technologies, and Eurogentec S.A. Increasing competition among key players in the custom primer generation services market is likely to fuel the growth of the market during forecast period.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Chromatography Resins Market Size, Status and Forecast to 2023

Chromatography is a process to separate mixtures of colored compounds into individual components. Resins are one of the important components of chromatographic techniques. It helps in isolation of desired component from mixtures of compounds. Resins have wide array of uses in gel filtration, ion-exchange, affinity, size exclusion, hydrophobic interaction and mixed-mode chromatographic techniques. Resins are usually incorporated into chromatography devices to cover a variety of industrial/research needs such as diagnostic test development, food & drug processing and purification, and separation of biomolecules. In chromatography based purification, choice of appropriate resin is an important step since resins are crucial for ensuring effective and accurate separation of individual components.
The chromatography resins market is significantly growing under the influence of emerging biopharmaceuticals, biotechnology and food and beverages industries. Increasing demand of resins for protein purification, monoclonal antibody production, drug assessment and food processing have triggered the growth of this market. Furthermore, huge investment in research and development by life science companies, extensive academic and industry collaborations and innovation in purification technology have also driven the global chromatography resins market. The increasing application of chromatography resins in drug discovery processes has increased its demand several folds in recent years. However, the presence of other advanced analytical techniques such as electrophoresis, protein crystallization, and charged ultra filtration membranes may hamper the growth of the chromatography reagents market globally.
The global chromatography resins market has been segmented by application, technique and product type. The chromatography resins market by application is segmented into pharmaceuticals, biotechnology, food and beverages, academic research and cosmetics. Among these biotechnology, pharmaceutical and food and beverages segments account for lion share of the total chromatography resins market. Different steps of food processing, monoclonal antibody production and purification consume huge amount of chromatography resins. The chromatography resins market by techniques includes ion exchange, affinity, mixed mode, size exclusion, hydrophobic interaction, nuclear, and others. Of these, ion exchange resins constitute the largest segment market in terms of volume. However, in terms of revenue, affinity chromatography resins dominate the market primarily due to high price of affinity resins. On the basis of product type, the global chromatography resins market is categorized organic, inorganic and synthetic. Organic chromatography resins such as agarose, dextran and cellulose have gained more market acceptance as compared to inorganic and synthetic resins.
Based on geography, the affinity chromatography resins market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). The North American region was recognized as the largest chromatography resins market across the globe in 2013. Ongoing robust research activities for the development of drugs and biologics and the presence of major pharmaceutical, biotechnology and food and beverages companies in the region are some of the driving factors in this region. Europe was the second-largest market for chromatography resins in 2013. Asia-Pacific is expected to be an fastest growing chromatography resins market during the forecast period from 2014 to 2020. This high growth is primarily due to improving economic condition in countries such as India, China and Malaysia and increasing number of contract manufacturing and contract research organizations in Asia-Pacific region.
Some of the key players in the chromatography resins include Bio-Rad Laboratories Inc., GE Healthcare Life Sciences, Sigma- Aldrich Corporation, Thermo Fisher Scientific, Inc., Life Technology Corporation, Purolite Corporation, Pall Corporation, Tosoh Corporation, Agilent Technologies, W.R. Grace & Co., Becton Dickinson & Co, Regis Technologies , Bio-Works Company Ltd, JSR Micro Inc., and Merck KGaA.
Posted by at No comments:
Labels:

Metagenomics Market Industry Demands, Top Key Players, Industry Analysis & Forecast By 2026

Metagenomics is the study of collective genomes of the members of a microbial community. It includes cloning and analyzing the genomes without culturing the organisms in the community. It involves study of genetic material recovered directly from environmental samples. It is the shotgun sequencing to DNA, obtained directly from an environmental sample. Metagenomics sequence is used to diagnose infectious diseases more rapidly with a more sensitive approach. Metagenomics is a major source of new antibiotics medicines, such as, Turbomycin A and Turbomycin B. Metagenomics provides an unlimited resource for the development of novel genes, natural products, enzymes, bioactive compounds, and bioprocesses that substantially impact industrial and biotechnological applications.
Rise in expansion of metagenomics applications, declining expenses of sequencing, development in biotechnology and bioinformatics techniques, and advancements related to DNA sequencing are driving the global metagenomics market. Furthermore, rising awareness regarding genetic disorders among people is boosting the growth of the global metagenomics market. For instance, in April 2018, Illumina, Inc. collaborated with WeGene (China’s leading personal genomics company). Together, they have established a leading human genome database in Asia which consists of more than 100,000 pieces of data obtained from consumers till date, and expecting to collect around 10,000 data per month in this year. This is anticipated to be a major breakthrough in metagenomics and bioinformatics field in the years to come. Major players acquired new companies and also invested significantly in R&D for identification of new antibiotics, enzymes, and bioactive compounds, seeking better opportunities to grow in the current global metagenomics market. However, high cost associated with metagenomics and shortage of skilled professionals are some of the factors anticipated to impact the global metagenomics market adversely in the next few years.
The global metagenomics market can be segmented based on product, technology, application, and region. In terms of product, the metagenomics market can be classified into instrument & software and consumable. The consumable segment held the major share of the market in 2017 and is expected to dominate the metagenomics market during the forecast period. The instrument & software segment is expected to grow significantly in the near future owing to evolution and advancements in software related to metagenomics. On the basis of technology, the global metagenomics market can be segmented into sequencing and bioinformatics. The sequencing segment is expected to grow substantially during the forecast period due to introduction of novel bioinformatics solutions, significant improvement in sequencing technology, and the availability of a large number of complementary technologies useful for DNA sequencing. Based on application, the global metagenomics market can be divided into environmental, human health, and others. The environmental segment held the major share of the metagenomics market in 2017. Environmental applications include biofuel, crop growth and fertilization, cleaning of oil spills, and others. Rise in research activities conducted for establishing relationship between microbe and human diseases or health is boosting the growth of human health segment.
In terms of region, the global metagenomics market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America dominated the global metagenomics market in 2017 and is expected to retain its position during the forecast period. Increase in implementing DNA sequencing across metagenomic applications and adoption of novel technologies for DNA sequencing are the drivers of the metagenomics market in the region. The metagenomics market in Asia Pacific is expected to grow at a significant CAGR during the forecast period due to continuous development in bioinformatics infrastructure in the emerging countries in the region, such as, China and India. Affordable health care and research are the other key factors contributing to the growth of metagenomics market in Asia Pacific.
Key players operating in the global metagenomics market include QIAGEN, F.Hoffmann-La Roche Ltd., Illumina, Inc., Novogene Corporation, Enterome SA, Pacific Biosciences of California, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Perkin Elmer Inc., Thermo Fisher Scientific, Inc., Merck KGaA, Luminex Corporation, Danaher, Oxford Gene Technology, Inc., IntegraGen Genomics, and Biocartis NV.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Surgical Robotics Market Size, Status and Forecast to 2026

Surgical robotics offers several benefits such as shorter hospital stay, rapid recovery, less post-operative pain, and lower risk of infections than open surgery. All these patient benefits along with better decision-making ability and greater precision from the surgeon’s viewpoint have led to rapid adoption of robotic surgical systems. For instance, the installed base of the da Vinci surgical system introduced by Intuitive Surgical, Inc., a pioneer in robotic surgical systems, increased from 2,966 systems in 2013 to 4,409 systems by the end of 2017. Surgical robots are medical devices that improve surgical outcomes by eliminating or reducing disadvantages in traditional surgery. Surgical robotic systems have been widely used for minimal invasive surgeries in specialties such as gynecology, cosmetology, open surgery, laparoscopic procedures, and flexible endoscopic procedures.
The global surgical robotics market is driven by technological advancements in the health care industry, increase in geriatric population, and high prevalence of movement-restricting medical conditions. Surge in health care costs, lack of skilled health care personnel, and rise in cost of labor are the other factors that have led to high demand for incorporation of lean operation methods in hospital management. However, high cost of surgical robots is a major factor restraining demand, especially in the developing markets. The growing trend of computer assisted or robotic minimally invasive surgery is expected to boost the growth of the surgical robotics market. Surgeons have adopted minimally invasive surgical (MIS) techniques for a wide range of applications such as cholecystectomy, appendectomy, prostatectomy, gastric bypass, ventral hernia repair, hysterectomy, colectomy, tubal ligation, and myomectomy. The number of cases of laparoscopic hysterectomy is projected to increase during the forecast period. About 96% of cholecystectomies is conducted laparoscopically. Hence, increase in acceptance and demand for surgical robots are expected to drive the global market.
The global surgical robotics market can be segmented based on product type, application, and region. In terms of product type, the market can be categorized into orthopedic robotic systems, neurosurgery robotic systems, general laparoscopy robotic systems, and steerable robotic catheters. Based on application, the global surgical robotics market can be divided into orthopedic surgery, interventional cardiology, general surgery, neurological surgery, urological surgery, and others.
In terms of region, the global surgical robotics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for major share of the global market in 2017 and the trend is anticipated to continue during the forecast period. Dominance of the region can be attributed to increase in adoption of robotic systems by hospitals, technological advancements, and rise in research and development on robotic systems for new applications. Moreover, better reimbursement policies and advanced health care infrastructure are the key drivers of the surgical robotics market in North America. Europe is also expected to account for significant market share owing to rise in prevalence of cancer and high demand for surgical robots for prostatectomy and hysterectomy surgeries, as these offer greater safety, accuracy, and precision. According to Cancer Research UK, between 2013 and 2015, over 360,000 new cancer cases were reported in the U.K. every year, which is nearly 990 per day. The surgical robotics market in Asia Pacific is likely to expand at a significant CAGR during the forecast period owing to surge in patient pool, rise in adoption of minimal invasive surgeries in the region, increase in research and developmental activities by surgical robotics manufacturers, and upcoming product approvals. According to the Wearable Robotics Association, there were over 2 million upper- and lower-extremity amputees in China in 2016. Also, more than 2.5 million new stroke cases are reported in the country each year. Furthermore, China is facing challenges due to the aging population. This is expected to create opportunities for prosthetics and exoskeleton robotics players in the surgical robotics market.
Key players operating in the global surgical robotics market are Intuitive Surgical, Inc., Accuray, Inc., Auris Surgical Robotics, TransEnterix, Inc., Think Surgical, Inc., Hansen Medical, Stryker Corporation, Smith & Nephew plc, Titan Medical, Inc., and Zimmer Biomet Holdings, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Wednesday, February 27, 2019

Intravascular Temperature Management Market: Size, Share, Emerging Trends, Analysis and Forecasts to 2026

Intravascular temperature management is a process which helps in achieving and maintaining a specific temperature in the patient’s body for a certain period of time. It mostly caters to hyperthermia, hypothermia, surgical procedures, and others. By using intravascular temperature management systems, a specified temperature is maintained in the patient’s body for further processes. It includes infusing hot or cold saline solution in the patient’s body via catheters in closed circuits. Patients are prevented from infections through temperature management while undergoing surgical process. Intravascular temperature management is also crucial in preventing post-operative and pre-hypothermia complications. Rise in initiatives by the government plays an important role in supporting the growth of the intravascular temperature management market during the forecast period.
The global intravascular temperature management market is projected to show promising growth in the next few years, attributed to the rising awareness of the procedure through public and private campaigns. Rapid acceptance of patient warming and cooling systems, growth of geriatric population, and technological advancements are the major factors driving the global market. Furthermore, rise in demand for temperature techniques due to increasing chronic and cardiac illnesses across the globe is boosting the market growth. Surgical procedures are performed on a large scale globally which is also a major contributor in the growth of the intravascular temperature management market. Rise in prevalence of nervous system diseases is creating need for temperature management techniques. However, surgical procedures are expensive and are not affordable to the majority of the patient population, which is likely to impede the growth of the global intravascular temperature market in the near future. Nevertheless, major companies are taking initiatives in investing in the market through mergers & acquisitions, partnerships, etc., which are projected to be create growth opportunities for the global intravascular temperature management market in the next few years. Also, untapped potential in the developing economies in the world is expected to boost the global market during the forecast period.
The global intravascular temperature market can be segmented based on product type, application, end-user, and region. Based on product type, the market can be classified into intravascular warming and intravascular cooling. The intravascular cooling segment is likely to grow rapidly in the next few years due to increase in awareness of the product in treatment of chronic cardiac conditions. In terms of application, the intravascular temperature management market can be bifurcated into acute care, perioperative care, new born care, and others. The perioperative care segment is leading the market owing to rise in incidence of chronic disorders, which require surgical interventions, followed with hypothermia. Based on end-user, the intravascular temperature management market can be divided into hospitals, ambulatory surgical centers, and others. By region, the global intravascular temperature management market can be classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global intravascular temperature management market owing to rise in demand for intravascular temperature techniques, technological advancements, well-developed health care infrastructure, increase in number of surgeries, surge in prevalence of cardiac arrest, neurological disorders, etc. in the region. North America is followed by Asia Pacific and Europe in terms of leading the global intravascular temperature market. Asia Pacific is likely to be the fastest growing market for intravascular temperature management in the near future owing to rise in prevalence in chronic illnesses, increase in surgical procedures, and growth in geriatric population in countries, such as, Japan, South Korea, and China, besides thriving investments made by key players in the region. Middle East & Africa and Latin America are the niche market for intravascular temperature management owing to the developing health care system in the regions.
Major players operating in the global intravascular temperature management market include ZOLL Medical Corporation, Smiths Group plc, Stryker, 3M, Medtronic, Becton Dickinson and Company, Belmont Instrument Corporation, Biegler GmbH, Geratherm Medical AG and The Surgical Company.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:

Hospital Furniture Market Current Trends & Opportunities by 2026

Hospital equipment is the most important part of hospitals. Hospital furniture includes all the essential features used in hospitals either by patients, staff, or physicians. Most hospitals develop their interior designs to attract patients. Factors such as an increase in the number of specialty clinics and hospitals due to a rise in the prevalence of chronic disorders and increase in demand from patients for better hospital infrastructure are expected to propel the global hospital furniture market during the forecast period. Moreover, continuous technological development and the launch of new products such as advanced stretcher chairs are estimated to people the global hospital furniture market.
An increase in the disposable income of people in emerging economies is likely to enable them to avail better health care facilities. An increase in income, growth in the baby boomer and disabled population, and availability of advanced imaging centers are expected to prompt health care service providers to make substantial investments in the development of technologically advanced health care infrastructure to satisfy patient needs, improve operational efficiency, and save both service costs and time. Moreover, a rise in the number of specialty surgical procedures, including ultrasound procedures, urology procedures, extracorporeal shockwave lithotripsy, diagnostic imaging procedures, and other specialty surgeries performed every year is boosting demand for new and replacement unit shipments of hospital furniture such as ICU solutions, ward care solutions, exam room solutions, transfer or mobility solutions, maternal and gynaec solutions, waiting area furniture, operation theater solutions, and bed accessories solutions across the globe. Developing hospital infrastructure in high growth potential countries, increase in per capita health care expenditure, and rise in the number of surgical procedures performed every year are some of the major factors expected to drive the global hospital furniture market from 2018 to 2026.
The global hospital furniture market can be segmented based on product, application, end-user, and geography. Based on product, the global hospital furniture market can be categorized into operation theatre tables, bedside tables, instruments stands, stretchers, waste containers, and others. In terms of application, the global hospital furniture market can be classified into physician’s furniture, patient’s furniture, and staff’s furniture. Based on end- user, the global hospital furniture market can be categorized into hospitals, nursing homes, diagnostic centers, specialty clinics, and others.
In terms of geography, the global hospital furniture market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global hospital furniture market, owing to the availability and increase in awareness about better health care facilities. Moreover, factors such as a rise in the number of specialty surgical procedures such as orthopedic surgeries, neurology surgeries, and other specialty surgeries performed every year is driving demand for new and advanced specialty hospital furniture market in the North America. The demand for new and advanced hospital furniture is increasing in developing countries such as China, India, Brazil, and countries in Middle East & Africa. The hospital furniture market in Asia Pacific is expected to expand at a rapid pace during the forecast period, as government initiatives in developing countries (such as the National Healthcare Protection Scheme in India to establish 24 new government medical hospitals) drive demand for new hospital furniture required for better hospital infrastructure.
Key players operating in the global hospital furniture market include Bharat Surgical Co., Stryker, Malvestio Spa - P.Iva, Drive DeVilbiss Sidhil Ltd., Hill-Rom Services Inc., Apex Medical Corp, Staan Bio-Med Engineering Private Limited, Linet, and Hirtz & Co. KG.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at 1 comment:
Labels:

Canal Hearing Aids Market: Shares, Strategies and Forecasts, Analysis and Overview upto 2025

Hearing aid is a small device used by a hearing-impaired person to amplify sound in order to capture it through an ear. Initially, ear devices were designed to gather sound energy in order to pass it into the ear canal. Modern devices are made of computerized electroacoustic systems that help to transform sound in a more intelligible and comfortable way. Audiologists play a vital role in configuring these devices in order to match the frequency with the physical features and lifestyle of the wearer. Hearing aid is not a solution for correction of hearing loss, rather to make the sound accessible to the ear. Various types of hearing instruments are available in different sizes, power, and circuitry.
In terms of type of hearing loss, the canal hearing aids market has been segmented into sensorineural hearing loss and conductive hearing loss. The sensorineural hearing loss segment is expected to grow at significant pace than the conductive hearing loss segment. Sensorineural hearing loss may result in missing or damage of sensory cells in the cochlea. With the help of hearing aids or implants, mild to severe sensorineural hearing loss can be rectified. Based on product type, the market has been categorized into in-the-canal, completely-in-canal, and invisible-in-canal. In terms of end-user, the canal hearing aids market has been segmented into adult canal hearing aids and pediatric canal hearing aids. High incidence of hearing loss due to noise pollution level and rising geriatric population fuel the growth of the market. Shortage of technical audiologists or hearing instrument specialists is restraining the global market. Several companies are developing devices that can be embedded in the ear and are not visible to reduce/prevent the social disgrace associated with such devices. Technological advancement and innovative connectivity features in devices help users have a better quality of life. Furthermore, introduction of digital signal processing devices, reduction in noise devices, and enhancement of speech features are expected to fuel the growth of the market.
The oldest strata above 85 years is becoming the fastest growing segment of the population in a majority of countries. This segment would constitute approximately 8% of the world’s population aged 65 and above, and the share is 12% in developed countries. This geriatric population is slated to grow at an exponential rate in two of the most populous countries globally — India and China. According to the statistics released by the World Population Prospects: the 2012 Revision (United Nations, Department of Economic and Social Affairs), the age group above 80 years, also referred as ‘oldest old’ in the report, was nearly 14% and is expected to increase to 19% by 2050. On the other hand, the population rise in under 65 age group is likely to be a mere 22%. Hence, rising geriatric population is likely to propel the global canal hearing aids market in the next few years.
In terms of region, the market in Europe is expected to expand at the highest growth rate, followed by North America. Rapid rise in geriatric population, growing incidence/increasing prevalence of hearing loss, and high purchasing power of patients is projected to augment the market in the region. Asia Pacific is expected to emerge as the fastest growing market. Developing countries in Asia Pacific such as India and China present significant expansion opportunities. Large patient pool, increasing geriatric population, and rising noise pollution drive the market in these countries. Increase in hearing-related problems, increasing awareness among patients about deafness, and expanding health care infrastructure are factors likely to boost the growth of the market in Latin America.
Cochlear Limited, GN Store Nord A/S, MED-EL, SeboTek Hearing Systems, LLC, Sivantos Pte. Ltd., Sonova, Starkey Hearing Technologies, Inc., Widex, William Demant Holding A/S, and Zounds Hearing, Inc. are the major players operating in the canal hearing aids market.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)